pyridomycin   Click here for help

GtoPdb Ligand ID: 13449

Synonyms: erizomycin
PDB Ligand
Compound class: Natural product
Comment: Pyridomycin is a natural product with potent antimycobacterial activity, produced by the Actinobacteria Streptomyces pyridomyceticus and Dactylosporangium fulvum, and which was first reported in 1953 [3]. It is an inhibitor of Mycobacterium enoyl acyl carrier protein reductase (InhA) [2], a clinically validated target and key enzyme involved in the synthesis of mycolic acid, an essential component of the mycobacterial cell wall.
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 12
Hydrogen bond donors 4
Rotatable bonds 6
Topological polar surface area 175.98
Molecular weight 540.57
XLogP 0.73
No. Lipinski's rules broken 2

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CC/C(=C\1/C(=O)O[C@H](C)[C@@H](C(=O)N[C@@H](CC2=CC=CN=C2)[C@H]([C@@H](C)C(=O)O1)O)NC(=O)C3=NC=CC=C3O)/C
Isomeric SMILES CC/C(=C\1/C(=O)O[C@@H]([C@@H](C(=O)N[C@H]([C@H]([C@H](C(=O)O1)C)O)CC2=CN=CC=C2)NC(=O)C3=C(C=CC=N3)O)C)/C
InChI InChI=1S/C27H32N4O8/c1-5-14(2)23-27(37)38-16(4)20(31-25(35)21-19(32)9-7-11-29-21)24(34)30-18(12-17-8-6-10-28-13-17)22(33)15(3)26(36)39-23/h6-11,13,15-16,18,20,22,32-33H,5,12H2,1-4H3,(H,30,34)(H,31,35)/b23-14-/t15-,16-,18+,20+,22+/m1/s1
InChI Key WHIKSLGSXKIHCA-IGCCMALHSA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

No information available.
Mechanism Of Action and Pharmacodynamic Effects Click here for help
Pyridomycin reduces mycolic acid synthesis in M. tuberculosis, by inhibiting InhA directly as a competitive inhibitor of the NADH‐binding site [2]. In a further study, the co-crystal structure revealed that pyridomycin blocks both the NADH cofactor- and lipid substrate-binding pockets of InhA [1].